Medical Doctor Program year 2020 Reported 2019–2020 Source: CMS Open Payments, 2026 publication

Kirk Scattergood

Retina Specialist Green Bay, WI Medical Doctor

NPI 1790702652 CMS profile 1183003

2253 W Mason St Ste 100, Green Bay, WI 54303

Open in the dashboard

General payments

$441

23 records reported · program years 2019–2020

Research payments

$0

Paid to them · None reported · program years 2019–2020

Ownership & investment interest

$0

None reported

Through program year 2020, Kirk Scattergood of Green Bay, WI is reported in the CMS Open Payments database as having received $441 across 23 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 15th percentile of Retina Specialist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2020 General $53 4
2019 General $388 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kirk Scattergood
  • Retina Specialist median
  • Middle half of Retina Specialist
  • National median

In program year 2025, general payments to Kirk Scattergood were reported at $0. Among 1,235 Retina Specialist profiles paid that year, the median was $457 and the middle half received between $175 and $1,079.

Show as a table
Year Kirk Scattergood Retina Specialist median Middle half National median
2019 $388 $410 $157–$1,517 $163
2020 $53 $168 $65–$778 $114
2021 $0 $258 $101–$1,161 $132
2022 $0 $418 $162–$1,488 $149
2023 $0 $476 $178–$1,312 $160
2024 $0 $520 $188–$1,372 $164
2025 $0 $457 $175–$1,079 $169

Breakdown

Who paid General payments · program years 2019–2020
  1. Novartis Pharmaceuticals Corporation $147 8 payments
  2. Alimera Sciences, Inc. $122 3 payments
  3. Allergan Inc. $51 4 payments
  4. Bausch & Lomb, a division of Bausch Health US, LLC $44 3 payments
  5. Regeneron Healthcare Solutions, Inc. $40 3 payments
  6. Shire North American Group Inc $23 1 payment
  7. New World Medical,Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2020
  1. Food and Beverage $441 23 payments
Products named General payments · program years 2019–2020
  1. ILUVIEN $122 3 payments
  2. TRAVATAN Z $108 5 payments
  3. EYLEA $40 3 payments
  4. STELLARIS PC $32 2 payments
  5. OZURDEX $24 2 payments
  6. XIIDRA Opthalmics $23 1 payment
  7. BEOVU $23 2 payments
  8. XIIDRA Ophthalmology $16 1 payment
  9. LUMIGAN $15 1 payment
  10. Kahook Dual Blade $14 1 payment
  11. Other $38 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

23 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Retina Specialist in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2020

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record